To all shareholders and shareholder representatives:
MuSi Health Sleep Co., Ltd. Independent Director 2025 Annual Performance Report (Li Feide)
As an independent director of MuSi Health Sleep Co., Ltd. (hereinafter referred to as the "Company"), in my work during 2025, I strictly followed the "Administrative Measures for Independent Directors of Listed Companies," "Corporate Governance Guidelines for Listed Companies," "Shenzhen Stock Exchange Stock Listing Rules," "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 1 – Normative Operation of Main Board Listed Companies," and the "Articles of Association," as well as other relevant laws, regulations, and company systems. I fully exercised my role as an independent director, regularly understood and reviewed the Company's operating conditions, diligently performed my duties as an independent director, acted with integrity and diligence, and effectively protected the overall interests of the Company and the legitimate rights and interests of all shareholders, especially small and medium shareholders. The report on my performance of independent director duties in 2025 is as follows:
I. Basic Information of Independent Directors
(I) Personal Work Experience, Professional Background, and Concurrent Positions
I, Li Feide, was born in April 1977, am a Chinese national with no permanent overseas residency, and hold a Master's degree. I previously served as Secretary of the Board of Directors, Director of Strategic Operations, Vice President, and Chairman of Midea Capital Investment Management Co., Ltd. I currently serve as an independent director of the Company and Chairman of Guangdong Kai Chuang Investment Co., Ltd.